CLINICAL_TRIALS
trial_result
· 2017-06-29
Clinical Trial Update: Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy [Phase 3]
Summary
A Phase 3 study is investigating intrauterine tranexamic acid to reduce blood loss during hysteroscopic myomectomy. The current status of the trial is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ain Shams University | Conditions: Surgical Blood Loss, Fibroid | Phase 3 | Status: UNKNOWN